Literatür Detay Bilgisi
Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia.
Yazarlar : Berthelot-Richer M,Boilard B, Morin A, Bolduc B, Beauregard P, Kotb R.
Yayın : Transfusion
Yayın Yılı : 2011
Pubmed Linki : http://www.ncbi.nlm.nih.gov/pubmed/22082044
Konu : Transfüzyon
Literatür İçeriği :
Abstract
BACKGROUND:
Refractoriness to platelet (PLT) transfusion is a feared, life-threatening complication in hematology-oncology patients. Despite increased PLT requirement and treatment costs, the clinical management is difficult and these patients had less favorable outcomes.
CASE REPORT:
We report on the efficacy of the thrombopoietic agent romiplostim in a patient with acute myeloid leukemia with chemotherapy-induced transfusion-refractory thrombocytopenia.
CONCLUSION:
Romiplostim could be very helpfull in the management of AML patients with transfusion refractory thrombocytopenia.Konusu Aynı Olan Diğer Materyaller
| Sunumlar | Videolar | Olgu Tartışması |
